TwinBeech Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
TwinBeech Capital's REGN Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 752 shares worth $570K. The stake represents 0.13% of the portfolio and ranks #211 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in REGN as recently as Q2 2025.
TwinBeech Capital first reported a position in REGN in Q4 2019 and has held it in 10 quarters since. The position peaked at $48.2M in Q3 2024. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- TwinBeech Capital held 752 shares of Regeneron Pharmaceuticals worth $570K as of Q3 2026.
- Regeneron Pharmaceuticals was a new TwinBeech Capital position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.13% of TwinBeech Capital's portfolio in Q3 2026, its #211 holding.
- TwinBeech Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 10 quarters since.
- TwinBeech Capital's Regeneron Pharmaceuticals position peaked at $48.2M in Q3 2024.
- 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.